269 related articles for article (PubMed ID: 30076115)
41. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
[TBL] [Abstract][Full Text] [Related]
42. Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.
Baker C; Grant AM; George MG; Grosse SD; Adamkiewicz TV
Pediatr Blood Cancer; 2015 Dec; 62(12):2076-81. PubMed ID: 26174777
[TBL] [Abstract][Full Text] [Related]
43. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
44. β
Abou-Elew HH; Youssry I; Hefny S; Hashem RH; Fouad N; Zayed RA
Hematology; 2018 Jul; 23(6):362-367. PubMed ID: 29157167
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.
Bhatnagar P; Barron-Casella E; Bean CJ; Milton JN; Baldwin CT; Steinberg MH; Debaun M; Casella JF; Arking DE
PLoS One; 2013; 8(9):e74193. PubMed ID: 24058526
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study.
Tang DC; Prauner R; Liu W; Kim KH; Hirsch RP; Driscoll MC; Rodgers GP
Am J Hematol; 2001 Nov; 68(3):164-9. PubMed ID: 11754397
[TBL] [Abstract][Full Text] [Related]
47. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in sickle cell disease: relation to vasculopathy and disease severity.
Tantawy AA; Adly AA; Ismail EA; Aly SH
Pediatr Blood Cancer; 2015 Mar; 62(3):389-94. PubMed ID: 25263931
[TBL] [Abstract][Full Text] [Related]
48. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
Armstrong-Wells J; Grimes B; Sidney S; Kronish D; Shiboski SC; Adams RJ; Fullerton HJ
Neurology; 2009 Apr; 72(15):1316-21. PubMed ID: 19365052
[TBL] [Abstract][Full Text] [Related]
49. Neuroimaging in assessment of risk of stroke in children with sickle cell disease.
Arkuszewski M; Melhem ER; Krejza J
Adv Med Sci; 2010; 55(2):115-29. PubMed ID: 21109500
[TBL] [Abstract][Full Text] [Related]
50. Development of a de novo cerebral arteriovenous malformation in a child with sickle cell disease and moyamoya arteriopathy. Case report.
O'Shaughnessy BA; DiPatri AJ; Parkinson RJ; Batjer HH
J Neurosurg; 2005 Mar; 102(2 Suppl):238-43. PubMed ID: 16156238
[TBL] [Abstract][Full Text] [Related]
51. Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study.
Seibert JJ; Glasier CM; Kirby RS; Allison JW; James CA; Becton DL; Kinder DL; Cox KS; Flick EL; Lairry F; Jackson JF; Graves RA
Pediatr Radiol; 1998 Mar; 28(3):138-42. PubMed ID: 9561529
[TBL] [Abstract][Full Text] [Related]
52. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, and GSTP1) in Egyptian pediatric patients with sickle cell disease.
Shiba HF; El-Ghamrawy MK; Shaheen IA; Ali RA; Mousa SM
Pediatr Dev Pathol; 2014; 17(4):265-70. PubMed ID: 24840051
[TBL] [Abstract][Full Text] [Related]
53. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial.
Kwiatkowski JL; Granger S; Brambilla DJ; Brown RC; Miller ST; Adams RJ;
Br J Haematol; 2006 Aug; 134(3):333-9. PubMed ID: 16848777
[TBL] [Abstract][Full Text] [Related]
54. Curative Therapies for Sickle Cell Disease.
Kaviany S; Barnawi Z; LaBelle J
Pediatr Ann; 2024 Feb; 53(2):e56-e61. PubMed ID: 38302122
[TBL] [Abstract][Full Text] [Related]
55. Gene coexpression networks analysis of sickle stroke risk.
Liu FF; Wang J; Hu F; Wei Q; Li K
J Cell Biochem; 2019 Sep; 120(9):15182-15189. PubMed ID: 31020690
[TBL] [Abstract][Full Text] [Related]
56. Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
Earley EJ; Kelly S; Fang F; Alencar CS; Rodrigues DOW; Soares Cruz DT; Flanagan JM; Ware RE; Zhang X; Gordeuk V; Gladwin M; Zhang Y; Nouraie M; Nekhai S; Sabino E; Custer B; Dinardo C; Page GP;
Br J Haematol; 2023 Apr; 201(2):343-352. PubMed ID: 36602125
[TBL] [Abstract][Full Text] [Related]
57. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
Mack AK; Thompson AA
J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
Bello-Manga H; DeBaun MR; Kassim AA
Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
[TBL] [Abstract][Full Text] [Related]
59. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation.
Bernaudin F; Verlhac S; Fréard F; Roudot-Thoraval F; Benkerrou M; Thuret I; Mardini R; Vannier JP; Ploix E; Romero M; Cassé-Perrot C; Helly M; Gillard E; Sebag G; Kchouk H; Pracros JP; Finck B; Dacher JN; Ickowicz V; Raybaud C; Poncet M; Lesprit E; Reinert PH; Brugières P
J Child Neurol; 2000 May; 15(5):333-43. PubMed ID: 10830200
[TBL] [Abstract][Full Text] [Related]
60. Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome.
Rallo MS; Akel O; Kalakoti P; Sun H
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106705. PubMed ID: 35964532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
